Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

被引:0
作者
Andrew W Ju
Hongkun Wang
Eric K Oermann
Benjamin A Sherer
Sunghae Uhm
Viola J Chen
Arjun V Pendharkar
Heather N Hanscom
Joy S Kim
Siyuan Lei
Simeng Suy
John H Lynch
Anatoly Dritschilo
Sean P Collins
机构
[1] LL Bles Building,Department of Radiation Medicine
[2] Georgetown University,Department of Biostatistics, Bioinformatics,and Biomathematics
[3] Georgetown University Hospital,Department of Urology
来源
Radiation Oncology | / 8卷
关键词
Stereotactic body radiotherapy; Prostate cancer; SBRT; CyberKnife; Intermediate-risk; Monotherapy; Hypofractionation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 289 条
[1]  
Miralbell R(2012)Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy Int J Radiat Oncol Biol Phys 82 e17-e24
[2]  
Roberts SA(2009)Hypofractionation for prostate cancer Cancer J 15 1-6
[3]  
Zubizarreta E(2011)Acute and Late Toxicity in a Randomized Trial of Conventional Versus Hypofractionated Three-Dimensional Conformal Radiotherapy for Prostate Cancer Int J Radiat Oncol Biol Phys 79 1013-1021
[4]  
Hendry JH(2008)Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations Int J Radiat Oncol Biol Phys 70 1588-1597
[5]  
Ritter M(2010)Dose Gradient Near Target–Normal Structure Interface for Nonisocentric CyberKnife and Isocentric Intensity-Modulated Body Radiotherapy for Prostate Cancer Int J Radiat Oncol Biol Phys 78 58-63
[6]  
Forman J(2008)Intrafractional Motion of the Prostate During Hypofractionated Radiotherapy Int J Radiat Oncol Biol Phys 72 236-246
[7]  
Kupelian P(2010)Stereotactic Body Radiotherapy as Boost for Organ-confined Prostate Cancer Technol Cancer Res T 9 575-582
[8]  
Lawton C(2010)A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer Technol Cancer Res Treat 9 453-462
[9]  
Petereit D(2008)A Phase II Study of High-Dose-Rate Afterloading Brachytherapy as Monotherapy for the Treatment of Localized Prostate Cancer Int J Radiat Oncol Biol Phys 72 441-446
[10]  
Arcangeli G(2011)High-Dose-Rate Monotherapy: Safe and Effective Brachytherapy for Patients With Localized Prostate Cancer Int J Radiat Oncol Biol Phys 81 1286-1292